NCT04264767View on ClinicalTrials.gov

Characterization of Methylation Patterns in Cancer and Non-Cancer cfDNA

CompletedOBSERVATIONAL
Enrollment

800

Participants

Timeline

Start Date

April 17, 2019

Primary Completion Date

January 30, 2021

Study Completion Date

January 30, 2021

Conditions
CancerSolid TumorHematologic Neoplasms
Interventions
PROCEDURE

Blood collection

Peripheral blood collection via routine venipuncture

Trial Locations (3)

90017

Los Angeles Hematology Oncology Medical Group - Good Samaritan Medical Offices, Los Angeles

91206

Los Angeles Hematology Oncology Medical Group - Wilson Terrace, Glendale

Unknown

Sourasky Medical Center, Tel Aviv

Sponsors

Lead Sponsor

Nucleix Ltd.
All Listed Sponsors
lead

Nucleix Ltd.

INDUSTRY

NCT04264767 - Characterization of Methylation Patterns in Cancer and Non-Cancer cfDNA | Biotech Hunter | Biotech Hunter